Swiss National Bank Boosts Stake in Tilray Brands, Inc. $TLRY

Swiss National Bank raised its stake in shares of Tilray Brands, Inc. (NASDAQ:TLRY) by 2.3% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 1,816,638 shares of the company’s stock after acquiring an additional 40,000 shares during the period. Swiss National Bank owned approximately 0.18% of Tilray Brands worth $1,194,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in TLRY. Geode Capital Management LLC raised its stake in Tilray Brands by 20.1% during the 4th quarter. Geode Capital Management LLC now owns 2,405,911 shares of the company’s stock valued at $3,200,000 after acquiring an additional 403,371 shares during the last quarter. Raymond James Financial Inc. acquired a new position in Tilray Brands during the fourth quarter worth $255,000. NewEdge Advisors LLC raised its holdings in Tilray Brands by 92.1% during the fourth quarter. NewEdge Advisors LLC now owns 27,406 shares of the company’s stock worth $36,000 after purchasing an additional 13,136 shares during the last quarter. Dimensional Fund Advisors LP grew its holdings in Tilray Brands by 54.8% during the 4th quarter. Dimensional Fund Advisors LP now owns 2,172,935 shares of the company’s stock valued at $2,890,000 after buying an additional 769,569 shares during the last quarter. Finally, TD Waterhouse Canada Inc. grew its holdings in Tilray Brands by 59.4% during the 4th quarter. TD Waterhouse Canada Inc. now owns 37,009 shares of the company’s stock valued at $49,000 after buying an additional 13,786 shares during the last quarter. 9.35% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several research firms have recently issued reports on TLRY. Wall Street Zen cut Tilray Brands to a “strong sell” rating in a report on Saturday, July 5th. Jefferies Financial Group increased their target price on Tilray Brands from $1.50 to $2.00 and gave the stock a “buy” rating in a research report on Monday. Finally, Zelman & Associates reaffirmed a “neutral” rating on shares of Tilray Brands in a research report on Tuesday, July 29th. Two research analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $1.94.

Tilray Brands Stock Up 20.9%

NASDAQ:TLRY opened at $1.39 on Tuesday. The company has a market capitalization of $1.53 billion, a price-to-earnings ratio of -0.60 and a beta of 1.85. Tilray Brands, Inc. has a one year low of $0.3507 and a one year high of $1.94. The stock has a 50-day simple moving average of $0.68 and a 200 day simple moving average of $0.61. The company has a debt-to-equity ratio of 0.20, a quick ratio of 1.49 and a current ratio of 2.46.

Tilray Brands (NASDAQ:TLRY) last posted its quarterly earnings results on Monday, July 28th. The company reported $0.02 EPS for the quarter, topping analysts’ consensus estimates of ($0.03) by $0.05. The business had revenue of $224.54 million during the quarter, compared to the consensus estimate of $250.41 million. Tilray Brands had a negative return on equity of 6.83% and a negative net margin of 265.69%. Sell-side analysts predict that Tilray Brands, Inc. will post -0.2 EPS for the current fiscal year.

Insider Buying and Selling

In related news, CEO Irwin D. Simon bought 165,000 shares of the firm’s stock in a transaction on Wednesday, July 30th. The stock was bought at an average cost of $0.61 per share, for a total transaction of $100,650.00. Following the completion of the purchase, the chief executive officer directly owned 3,941,633 shares in the company, valued at approximately $2,404,396.13. The trade was a 4.37% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 0.60% of the stock is currently owned by insiders.

Tilray Brands Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.